AAP
ANGO icon

Arax Advisory Partners’s AngioDynamics ANGO Stock Holding History

Arax Advisory Partners’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.7K Buy
2,895
+2,152
+290% +$24.5K ﹤0.01% 3499
2026
Q1 		$8.45K Buy
743
+157
+27% +$1.7K ﹤0.01% 2538
2025
Q4 		$7.53K Sell
586
-91
-13% -$1.12K ﹤0.01% 2628
2025
Q3 		$7.56K Buy
677
+537
+384% +$5.18K ﹤0.01% 2716
2025
Q2 		$1.39K Hold
140
– – ﹤0.01% 2675
2025
Q1 		$1.31K Sell
140
-586
-81% -$6.16K ﹤0.01% 2222
2024
Q4 		$6.65K Buy
726
+140
+24% +$1.03K ﹤0.01% 1636
2024
Q3 		$4.56K Hold
586
– – ﹤0.01% 1757
2024
Q2 		$3.55K Buy
+586
New +$3.62K ﹤0.01% 1739

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arax Advisory Partners's ANGO Position: Q2 2026 in Review

Arax Advisory Partners increased its AngioDynamics (ANGO) stake by 290% in Q2 2026, buying an estimated $24.5K and bringing the position to 2,895 shares worth $37.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3499.

Arax Advisory Partners first reported a position in ANGO in Q2 2024 and has held it in 9 quarters since. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Arax Advisory Partners held 2,895 shares of AngioDynamics worth $37.7K as of Q2 2026.
  • Arax Advisory Partners bought 2,152 AngioDynamics shares in Q2 2026, an estimated $24.5K.
  • AngioDynamics made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3499 holding.
  • Arax Advisory Partners first reported a position in AngioDynamics in Q2 2024 and has held it in 9 quarters since.
  • 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.